NCT05711914View on ClinicalTrials.gov

Predicting Response to PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging and Clinical Data

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

December 31, 2022

Conditions

Non-small Cell Lung Cancer (NSCLC)

Trial Locations (1)

30900

Jean-Paul BEREGI, Nîmes

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

MEDEXPRIM

UNKNOWN

collaborator

GRATICULE

UNKNOWN

lead

Centre Hospitalier Universitaire de Nīmes

OTHER